(Q56674419)

https://api.crossref.org/works/10.1002%2FCLC.4960281307

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

Mortality benefit of immediate revascularization of acute ST-segment elevation myocardial infarction in patients with contraindications to thrombolytic therapy: a propensity analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

Predictors of door-to-balloon delay in primary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

Is primary angioplasty for some as good as primary angioplasty for all?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE)

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

Comparison of pre-hospital combination-fibrinolysis plus conventional care with pre-hospital combination-fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

Fundamentals of reperfusion injury for the clinical cardiologist.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

Nicorandil versus isosorbide dinitrate as adjunctive treatment to direct balloon angioplasty in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

Trends in acute myocardial infarction management: use of the National Registry ofMyocardial Infarction in quality improvement

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021

Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281307

7 January 2021